Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Statement regarding AutoStore

11 Mar 2022 08:01

RNS Number : 4880E
Ocado Group PLC
11 March 2022
Β 

OCADO GROUP PLC

11 March 2022

Β 

Ocado Group plc

ITC investigation over: conclusive victory for Ocado

ITC confirms all AutoStore cavity bot patents are invalid

On 10th March, the International Trade Commission, consisting of 5 experienced patent judges, decided in favour of Ocado on all points. Every patent AutoStore asserted in its ITC complaint was found either invalid or not infringed by Ocado's proprietary state of the art technology.

All of the 33 claims that originally constituted AutoStore's complaint to the ITC have now been rejected for a second time, or abandoned by AutoStore. AutoStore's key cavity bot patents, the UK versions of which are the only patents being asserted against Ocado in the High Court case starting next week, were all found to be invalid. A fourth, unrelated, patent was held not to be infringed.

Unusually, the ITC accepted review of the judge's original decision and in the same notice gave its decision on the merits, which further emphasises the strength of these findings.

Ocado continues actively to pursue its claims against AutoStore for infringement of Ocado's IP rights in both the United States and Europe, including its antitrust "Walker Process" claim against AutoStore in East Virginia and its infringement of five Ocado patents in New Hampshire. Ocado anticipates court determinations injuncting AutoStore and awarding Ocado damages for AutoStore's infringement of Ocado's patents.

An Ocado spokesperson said:

"We welcome the ITC's decision, which comprehensively confirms the judge's original findings last December. All 33 of the patent claims asserted against Ocado have now been confirmed for a second time to be either invalid or not infringed, demonstrating again how misguided AutoStore's complaint has been. The ITC investigation is now at its end.

Β 

We expect further vindication in the High Court in London in the weeks ahead, where AutoStore has already abandoned half of the patents in the case."

Β 

Contacts

● David Shriver, Director of Communications, Ocado Group plc, on 01707 228 000

● Martin Robinson at Tulchan Communications on 020 7353 4200

Β 

Β 

Β 

Person responsible for arranging the release of this announcement:

Β 

Neill Abrams

Group General Counsel & Company Secretary

Ocado Group plc

Buildings One & Two

Trident Place

Mosquito Way

Hatfield

Hertfordshire AL10 9UL

Fax: +44 (0)1707 227 997

email: company.secretary@ocado.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRFIFEDVAILLIF
Date   Source Headline
27th Jul 20213:14 pmRNSBlock listing Interim Review
21st Jul 20211:45 pmRNSDirector/PDMR Shareholding
19th Jul 20215:34 pmRNSDirector/PDMR Shareholding
16th Jul 202112:34 pmRNSDirector/PDMR Shareholding
6th Jul 20217:02 amRNSAnnouncement of partnership with Alcampo
6th Jul 20217:00 amRNSHalf-year Report
1st Jul 20215:06 pmRNSTotal Voting Rights
1st Jul 20214:17 pmRNSDirector/PDMR Shareholding
15th Jun 20215:31 pmRNSDirector/PDMR Shareholding
1st Jun 202112:26 pmRNSTotal Voting Rights
18th May 202110:09 amRNSDirector/PDMR Shareholding
13th May 20216:14 pmRNSResult of AGM
13th May 20217:00 amRNSHolding(s) in Company
11th May 202112:44 pmRNSDirector/PDMR Shareholding
7th May 20216:26 pmRNSDirector/PDMR Shareholding
4th May 20215:42 pmRNSTotal Voting Rights
28th Apr 20214:44 pmRNSDirector/PDMR Shareholding
23rd Apr 20215:22 pmRNSDirector/PDMR Shareholding
16th Apr 20213:39 pmRNSDirector/PDMR Shareholding
16th Apr 20217:00 amRNSOcado Invests in Oxbotica
13th Apr 20219:04 amRNSChange of Director's Details
1st Apr 202111:17 amRNSTotal Voting Rights
25th Mar 20218:00 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
22nd Mar 20216:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20216:21 pmRNSDirector/PDMR Shareholding
22nd Mar 202112:34 pmRNSDirector/PDMR Shareholding
22nd Mar 202110:06 amRNSDirector/PDMR Shareholding
18th Mar 20219:25 amRNSDirector/PDMR Shareholding
18th Mar 20217:00 amRNSTrading Statement
9th Mar 20214:24 pmRNSAdditional Listing
1st Mar 20213:59 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSHolding(s) in Company
17th Feb 20216:15 pmRNSDirector/PDMR Shareholding
16th Feb 20213:24 pmRNSNotice of AGM
15th Feb 20217:15 amRNSDirectorate Appointment Date
12th Feb 20212:54 pmRNSDirector/PDMR Shareholding
10th Feb 20214:05 pmRNSDirector/PDMR Shareholding
9th Feb 202112:00 pmRNSAnnual Financial Report
9th Feb 20217:00 amRNSFinal Results
2nd Feb 20218:57 amRNSDirectorate Change
1st Feb 20212:20 pmRNSTotal Voting Rights
27th Jan 20219:05 amRNSBlock listing Interim Review
5th Jan 20215:17 pmRNSTotal Voting Rights
21st Dec 20203:31 pmRNSCompletion of Acquisition
18th Dec 20206:25 pmRNSDirectorate Change
16th Dec 20205:43 pmRNSDirector/PDMR Shareholding
15th Dec 20207:00 amRNSCompletion of Acquisition
10th Dec 20207:00 amRNSTrading Statement
1st Dec 202012:53 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.